CONMED | CNMD - Current Assets


CONMED reported $672.86M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
3M USD 16.39B 298M Dec/2025
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
CONMED USD 672.86M 10.7M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Olympus JPY 652.65B 47.58B Dec/2025
Orthofix International USD 416.85M 22.68M Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025